Skip to main content

Advertisement

Log in

The Mucosal Immune Response to Plant-Derived Vaccines

  • Commentary
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

ABSTRACT

Transgenic plants present enormous potential as one of the most cost-effective and safe systems for large-scale production of proteins for industrial, pharmaceutical, veterinary and agricultural uses. Heat-stable plant-derived vaccines that are administered orally could in effect enhance vaccine coverage in children and infants, particularly in developing countries. Here we discuss the current status of plant-derived vaccines and their potential to champion the battle against infectious diseases in the least developed countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Thanavala Y, Huang Z, Mason HS. Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead. Expert Rev Vaccin. 2006;5(2):249–60.

    Article  CAS  Google Scholar 

  2. McDonald KA, Hong LM, Trombly DM, Xie Q, Jackman AP. Production of human alpha-1-antitrypsin from transgenic rice cell culture in a membrane bioreactor. Biotechnol Prog. 2005;21(3):728–34.

    Article  CAS  PubMed  Google Scholar 

  3. Limaye A, Koya V, Samsam M, Daniell H. Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system. FASEB J. 2006;20(7):959–61.

    Article  CAS  PubMed  Google Scholar 

  4. Bardor M, Cabrera G, Rudd PM, Dwek RA, Cremata JA, Lerouge P. Analytical strategies to investigate plant N-glycan profiles in the context of plant-made pharmaceuticals. Curr Opin Struct Biol. 2006;16(5):576–83.

    Article  CAS  PubMed  Google Scholar 

  5. Tacket CC. Plant based oral vaccines: results of human trials. Curr Top Microbiol Immunol. 2009;332:103–17.

    Article  CAS  PubMed  Google Scholar 

  6. Ko K, Koprowski H. Plant biopharming of monoclonal antibodies. Virus Res. 2005;111(1):93–100.

    Article  CAS  PubMed  Google Scholar 

  7. Villani ME, Morgun B, Brunetti P, Marusic C, Lombardi R, Pisoni I, et al. Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies. Plant Biotechnol J. 2009;7(1):59–72.

    Article  CAS  PubMed  Google Scholar 

  8. Takagi H, Hirose S, Yasuda H, Takaiwa F. Biochemical safety evaluation of transgenic rice seeds expressing T cell epitopes of Japanese cedar pollen allergens. J Agric Food Chem. 2006;54(26):9901–5.

    Article  CAS  PubMed  Google Scholar 

  9. Smart V, Foster PS, Rothenberg ME, Higgins TJ, Hogan SP. A plant-based allergy vaccine suppresses experimental asthma via an IFN-gamma and CD4+CD45RBlow T cell-dependent mechanism. J Immunol. 2003;171(4):2116–26.

    CAS  PubMed  Google Scholar 

  10. Beyer AJ, Wang K, Umble AN, Wolt JD, Cunnick JE. Low-dose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit. Environ Health Perspect. 2007;115(3):354–60.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kathleen Laura Hefferon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hefferon, K.L. The Mucosal Immune Response to Plant-Derived Vaccines. Pharm Res 27, 2040–2042 (2010). https://doi.org/10.1007/s11095-010-0168-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-010-0168-9

KEYWORDS

Navigation